ID   LANCEi020-A-4
AC   CVCL_A0KX
SY   iPS-16-FBN1-HI1; IPSC16-FBN1-HI1
DR   hPSCreg; LANCEi020-A-4
DR   Wikidata; Q108820660
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=34174776; DOI=10.1016/j.scr.2021.102434;
RA   Borsoi, Juliana
RA   Farinha-Arcieri, Luis Ernesto
RA   Morato-Marques, Mariana
RA   Sarafian, Raquel Delgado
RA   Pinheiro, Mara
RA   Pereira, Lygia Veiga
RT   "Generation of genetically modified human induced pluripotent stem
RT   cell lines harboring haploin sufficient or dominant negative variants
RT   in the FBN1 gene.";
RL   Stem Cell Res. 54:102434-102434(2021).
//